326 related articles for article (PubMed ID: 20546727)
1. Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts.
Mohan RR; Gupta R; Mehan MK; Cowden JW; Sinha S
Exp Eye Res; 2010 Aug; 91(2):238-45. PubMed ID: 20546727
[TBL] [Abstract][Full Text] [Related]
2. Role of
Gupta S; Martin LM; Sinha NR; Smith KE; Sinha PR; Dailey EM; Hesemann NP; Mohan RR
Mol Vis; 2020; 26():742-756. PubMed ID: 33273801
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin a inhibits corneal haze in vitro and in vivo.
Sharma A; Mehan MM; Sinha S; Cowden JW; Mohan RR
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2695-701. PubMed ID: 19168895
[TBL] [Abstract][Full Text] [Related]
4. Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts.
Jester JV; Huang J; Fisher S; Spiekerman J; Chang JH; Wright WE; Shay JW
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1850-8. PubMed ID: 12714615
[TBL] [Abstract][Full Text] [Related]
5. Latrunculin B and substratum stiffness regulate corneal fibroblast to myofibroblast transformation.
Thomasy SM; Raghunathan VK; Miyagi H; Evashenk AT; Sermeno JC; Tripp GK; Morgan JT; Murphy CJ
Exp Eye Res; 2018 May; 170():101-107. PubMed ID: 29421383
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer.
Sharma A; Rodier JT; Tandon A; Klibanov AM; Mohan RR
Mol Vis; 2012; 18():2598-607. PubMed ID: 23112572
[TBL] [Abstract][Full Text] [Related]
7. Modulation of human corneal stromal cell differentiation by hepatocyte growth factor and substratum compliance.
Miyagi H; Jalilian I; Murphy CJ; Thomasy SM
Exp Eye Res; 2018 Nov; 176():235-242. PubMed ID: 30193807
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly.
Jester JV; Huang J; Barry-Lane PA; Kao WW; Petroll WM; Cavanagh HD
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1959-67. PubMed ID: 10440249
[TBL] [Abstract][Full Text] [Related]
9. Substratum topography modulates corneal fibroblast to myofibroblast transformation.
Myrna KE; Mendonsa R; Russell P; Pot SA; Liliensiek SJ; Jester JV; Nealey PF; Brown D; Murphy CJ
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):811-6. PubMed ID: 22232431
[TBL] [Abstract][Full Text] [Related]
10. Substratum compliance modulates corneal fibroblast to myofibroblast transformation.
Dreier B; Thomasy SM; Mendonsa R; Raghunathan VK; Russell P; Murphy CJ
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5901-7. PubMed ID: 23860754
[TBL] [Abstract][Full Text] [Related]
11. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.
Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP
Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289
[TBL] [Abstract][Full Text] [Related]
12. Effects of decorin on the expression of alpha-smooth muscle actin in a human myofibroblast cell line.
Nakatani T; Honda E; Hayakawa S; Sato M; Satoh K; Kudo M; Munakata H
Mol Cell Biochem; 2008 Jan; 308(1-2):201-7. PubMed ID: 17952560
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro.
Tripathi R; Sinha NR; Kempuraj D; Balne PK; Landreneau JR; Juneja A; Webel AD; Mohan RR
Exp Eye Res; 2022 Jul; 220():109113. PubMed ID: 35588782
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta-3 localization in the corneal response to epithelial-stromal injury and effects on corneal fibroblast transition to myofibroblasts.
Shiju TM; Sampaio LP; Martinez VV; Hilgert GSL; Wilson SE
Exp Eye Res; 2023 Oct; 235():109631. PubMed ID: 37633325
[TBL] [Abstract][Full Text] [Related]
15. The effect of growth factor supplementation on corneal stromal cell phenotype in vitro using a serum-free media.
Lynch AP; O'Sullivan F; Ahearne M
Exp Eye Res; 2016 Oct; 151():26-37. PubMed ID: 27456135
[TBL] [Abstract][Full Text] [Related]
16. ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.
Lim RR; Tan A; Liu YC; Barathi VA; Mohan RR; Mehta JS; Chaurasia SS
Sci Rep; 2016 Feb; 6():20841. PubMed ID: 26865052
[TBL] [Abstract][Full Text] [Related]
17. Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.
Andreae EA; Warejcka DJ; Twining SS
Mol Vis; 2020; 26():540-562. PubMed ID: 32818017
[TBL] [Abstract][Full Text] [Related]
18. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
19. Decorin biology, expression, function and therapy in the cornea.
Mohan RR; Tovey JC; Gupta R; Sharma A; Tandon A
Curr Mol Med; 2011 Mar; 11(2):110-28. PubMed ID: 21342131
[TBL] [Abstract][Full Text] [Related]
20. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.
Kaur H; Chaurasia SS; Agrawal V; Suto C; Wilson SE
Exp Eye Res; 2009 Aug; 89(2):152-8. PubMed ID: 19285499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
